|
|
|
Insider
Information: |
Karsen Perry A |
Relationship: |
Director |
City: |
Rockville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
272,994 |
|
Indirect Shares
|
1,639 |
|
|
Direct
Value |
$7,308,556 |
|
|
Indirect Value
|
$177,405 |
|
|
Total
Shares |
274,633 |
|
|
Total
Value |
$7,485,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-35.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
see remarks |
2015-12-17 |
66,432 |
2015-12-17 |
1,639 |
Premium* |
|
Navidea Biopharmaceuticals |
NAVB |
Director |
2015-07-16 |
37,528 |
2014-02-17 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
Director |
2023-05-03 |
0 |
2017-02-01 |
0 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2020-12-17 |
5,000 |
2017-06-01 |
0 |
Premium* |
|
Graphite Bio, Inc. |
GRPH |
Director |
2021-06-29 |
164,034 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
JNCE |
Jounce Therapeutics Inc |
Director |
|
2023-05-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
GRPH |
Graphite Bio, Inc. |
Director |
|
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,126 |
164,034 |
0 |
- |
|
GRPH |
Graphite Bio, Inc. |
Director |
|
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
155,908 |
|
- |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2020-12-17 |
4 |
AS |
$52.52 |
$4,753,680 |
D/D |
(88,764) |
5,000 |
0 |
% |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2020-12-17 |
4 |
OE |
$14.35 |
$1,637,842 |
D/D |
88,764 |
93,764 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2017-06-01 |
4 |
A |
$11.99 |
$59,925 |
D/D |
5,000 |
5,000 |
0 |
- |
|
JNCE |
Jounce Therapeutics Inc |
Director |
|
2017-02-01 |
4 |
B |
$16.00 |
$80,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-12-17 |
4 |
D |
$112.17 |
$436,117 |
D/D |
(3,888) |
66,432 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
70,320 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-10-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
65,432 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2015-07-16 |
4 |
D |
$0.01 |
$220 |
D/D |
(22,000) |
37,528 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-05-13 |
4 |
OE |
$36.47 |
$1,491,296 |
D/D |
30,470 |
109,993 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-04-30 |
4 |
D |
$108.06 |
$627,504 |
D/D |
(5,807) |
79,523 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,200 |
85,330 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2015-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
59,528 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-03-01 |
4 |
D |
$121.53 |
$525,131 |
D/D |
(4,321) |
74,130 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,334 |
78,451 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-02-11 |
4 |
AS |
$120.12 |
$3,350,728 |
D/D |
(27,896) |
70,117 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-02-11 |
4 |
OE |
$34.70 |
$1,046,520 |
D/D |
27,896 |
98,013 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-02-06 |
4 |
D |
$118.75 |
$1,871,263 |
D/D |
(15,758) |
70,117 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,404 |
85,875 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2015-02-05 |
4 |
A |
$1.89 |
$13,752 |
D/D |
7,276 |
37,528 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-12-30 |
4 |
AS |
$113.37 |
$2,184,980 |
D/D |
(19,273) |
55,471 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-12-30 |
4 |
OE |
$29.75 |
$694,187 |
D/D |
23,334 |
74,744 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2014-11-12 |
4 |
OE |
$25.77 |
$1,055,391 |
D/D |
32,074 |
90,830 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|